Interleukin-11 receptor expression in primary ovarian carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The interleukin-11 receptor alpha subunit (IL-11Ralpha) and its signaling co-receptor gp130 are crucial for cellular responses to IL-11.
• Understanding their expression and the role of IL-11 in ovarian cancer is important for potential therapeutic strategies.

Purpose of the Study:

• To determine the frequency of IL-11Ralpha and gp130 expression in primary ovarian carcinomas.
• To assess the expression of IL-11 in ovarian malignancies.
• To investigate the potential role of IL-11 in ovarian cancer cell biology.

Main Methods:

• Immunohistochemical assays were used to detect IL-11Ralpha and gp130 expression in ovarian tissues.
• Reverse transcription polymerase chain reaction (RT-PCR) was employed to determine IL-11 mRNA levels.
• In vitro assays (e.g., [3H]thymidine incorporation, ELISA) were conducted to assess IL-11's functional effects on ovarian cancer cell lines.

Main Results:

• IL-11Ralpha and gp130 were highly expressed (over 93%) in malignant epithelial cells of primary ovarian carcinomas.
• Coexpression of IL-11Ralpha and gp130 was also common in benign ovarian tumors and normal ovarian tissues.
• IL-11 mRNA expression was detected in only 14.3% of malignant samples.
• Recombinant IL-11 did not stimulate proliferation or inhibit apoptosis in tested ovarian cancer cell lines.

Conclusions:

• The IL-11 receptor system is widely expressed in both malignant and nonmalignant ovarian tissues.
• The functional significance of IL-11 signaling in ovarian epithelial cell biology remains undetermined.
• Further research is needed to elucidate the precise role of IL-11 in ovarian cancer pathogenesis.